2017 annual financial data

Voyager Therapeutics 2017 Net margin

Voyager Therapeutics 2017 net margin with verified reported values.

Direct answer

Net margin was -697.56%.

Operating income was -71,863,000 USD and net income was -70,698,000 USD.
Operating cash flow was -61,350,000 USD.

Get free Voyager Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
10,135,000 USD
Operating income
-71,863,000 USD
Net income
-70,698,000 USD
Operating cash flow
-61,350,000 USD